Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry S Cooper

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Gastroenterology|December 7, 2007
Toll-like receptor-4 promotes the development of colitis-associated colorectal tumorsMasayuki Fukata, Anli Chen, Arunan S Vamadevan, et al.
Cancers|June 10, 2023
Folic Acid Supplementation Promotes Hypomethylation in Both the Inflamed Colonic Mucosa and Colitis-Associated DysplasiaWen-Chi L Chang, Jayashri Ghosh, Harry S Cooper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2013
Quantification of excision repair cross-complementing group 1 and survival in p16-negative squamous cell head and neck cancersRanee Mehra, Fang Zhu, Dong-Hua Yang, et al.
American Journal of Clinical Oncology|March 18, 2016
Induction Therapy for Locally Advanced, Resectable Esophagogastric Cancer: A Phase I Trial of Vandetanib (ZD6474), Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiotherapy Followed by ResectionPatrick M Boland, Joshua E Meyer, Adam C Berger, et al.
Cancer Research|September 17, 2008
One-hit effects in cancer: altered proteome of morphologically normal colon crypts in familial adenomatous polyposisAnthony T Yeung, Bhavinkumar B Patel, Xin-Ming Li, et al.
Inflammatory Bowel Diseases|June 16, 2011
Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesisMasayuki Fukata, Limin Shang, Rebeca Santaolalla, et al.
Clinical Colorectal Cancer|September 25, 2020
First-in-Human Phase 1b Trial of Quinacrine Plus Capecitabine in Patients With Refractory Metastatic Colorectal CancerArthur Winer, Crystal S Denlinger, Namrata Vijayvergia, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 6, 2007
Colon cancerPaul F Engstrom, Juan Pablo Arnoletti, Al B Benson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 6, 2007
Rectal cancerPaul F Engstrom, Juan Pablo Arnoletti, Al B Benson, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 29, 2021
Suppression of Colon Tumorigenesis in Mutant <i>Apc</i> Mice by a Novel PDE10 Inhibitor that Reduces Oncogenic β-CateninKevin J Lee, Wen-Chi L Chang, Xi Chen, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Gastroenterology|December 7, 2007
Toll-like receptor-4 promotes the development of colitis-associated colorectal tumorsMasayuki Fukata, Anli Chen, Arunan S Vamadevan, et al.
Cancers|June 10, 2023
Folic Acid Supplementation Promotes Hypomethylation in Both the Inflamed Colonic Mucosa and Colitis-Associated DysplasiaWen-Chi L Chang, Jayashri Ghosh, Harry S Cooper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2013
Quantification of excision repair cross-complementing group 1 and survival in p16-negative squamous cell head and neck cancersRanee Mehra, Fang Zhu, Dong-Hua Yang, et al.
American Journal of Clinical Oncology|March 18, 2016
Induction Therapy for Locally Advanced, Resectable Esophagogastric Cancer: A Phase I Trial of Vandetanib (ZD6474), Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiotherapy Followed by ResectionPatrick M Boland, Joshua E Meyer, Adam C Berger, et al.
Cancer Research|September 17, 2008
One-hit effects in cancer: altered proteome of morphologically normal colon crypts in familial adenomatous polyposisAnthony T Yeung, Bhavinkumar B Patel, Xin-Ming Li, et al.
Inflammatory Bowel Diseases|June 16, 2011
Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesisMasayuki Fukata, Limin Shang, Rebeca Santaolalla, et al.
Clinical Colorectal Cancer|September 25, 2020
First-in-Human Phase 1b Trial of Quinacrine Plus Capecitabine in Patients With Refractory Metastatic Colorectal CancerArthur Winer, Crystal S Denlinger, Namrata Vijayvergia, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 6, 2007
Colon cancerPaul F Engstrom, Juan Pablo Arnoletti, Al B Benson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 6, 2007
Rectal cancerPaul F Engstrom, Juan Pablo Arnoletti, Al B Benson, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 29, 2021
Suppression of Colon Tumorigenesis in Mutant <i>Apc</i> Mice by a Novel PDE10 Inhibitor that Reduces Oncogenic β-CateninKevin J Lee, Wen-Chi L Chang, Xi Chen, et al.
Pageof 7